Description
In this presentation, Xavier Griffin from Barts discusses an innovative program that aims to significantly enhance clinical practice and patient outcomes in the UK. He expresses excitement about how this initiative will revolutionize the types of procedures and implants used in patient care. Griffin emphasizes the importance of high-quality research in improving healthcare outcomes, highlighting recent studies presented at a conference that showcase the community's contributions to this field.
He outlines the unique aspect of this program, stating that it is clinically driven with integrated research and innovation components from the outset, rather than retrofitting them later, which he views as a breakthrough approach. The program aspires to cover the entire lifecycle of medical devices—from discovery and development through to post-market surveillance—ensuring rigorous oversight and improvement of device safety and efficacy.
The initiative also incorporates patient input and clinical perspectives in its design and execution. Griffin describes how the program will provide better data access, curation, and governance, which have been challenging hurdles in current registries. The goal is to streamline the research process through a linked platform that integrates various studies within the National Institute for Health Research (NIHR) framework, facilitating patient recruitment and data management.
Part of the program involves the establishment of a comprehensive data collection system that will allow for patient randomization and tracking throughout their treatment journey, setting a benchmark for international practices in clinical research. Lastly, Griffin emphasizes collaboration with regulatory bodies and industry partners to ensure that the UK becomes the premier environment for medical device innovation, driven by data-informed regulations and patient-centric practices.